OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AVEU58

Avenue Supermarts Ltd

Food Retail & DistributionVerified

Avenue Supermarts Ltd maintains a strong liquidity position, with a current ratio of 3.13, indicating the company can cover its short-term liabilities more than three times over. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity risk. The company's debt-to-equity ratio is 0.03, suggesting a conservative capital structure with minimal reliance on debt financing. In terms of profitability, the company's return on equity (ROE) is 3.01%, and its return on assets (ROA) is 2.66%. These figures are below the industry median for ROE and ROA in the Food Retail & Distribution sector, indicating that the company is underperforming its peers in terms of capital efficiency and asset utilization. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes. The company's operating cash flow of INR 27.46 billion supports its capital expenditures of INR 27.31 billion, suggesting that the company is reinvesting heavily in its operations. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. The company's capital expenditures are expected to remain high, driven by the need to expand its retail footprint and modernize its stores. The company's dilution risk is currently low, with no near-term pressure to issue additional shares. Recent filings and transcripts indicate that the company is focused on maintaining its market leadership in the Indian retail sector. The company has not disclosed any material risks or strategic shifts in its recent filings, suggesting a stable business environment.

30-day price · AVEU+87.60 (+2.1%)
Low$4066.10High$4644.00Close$4358.70As of17 May, 00:00 UTC
Profile
CompanyAvenue Supermarts Ltd
TickerAVEU.NS
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Avenue Supermarts Ltd operates as a food and drug retailer in India, generating revenue primarily through the sale of groceries, household products, and pharmaceuticals.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a confidence level of 0.92.

Avenue Supermarts Ltd maintains a strong liquidity position, with a current ratio of 3.13, indicating the company can cover its short-term liabilities more than three times over. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity risk. The company's debt-to-equity ratio is 0.03, suggesting a conservative capital structure with minimal reliance on debt financing. In terms of profitability, the company's return on equity (ROE) is 3.01%, and its return on assets (ROA) is 2.66%. These figures are below the industry median for ROE and ROA in the Food Retail & Distribution sector, indicating that the company is underperforming its peers in terms of capital efficiency and asset utilization. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes. The company's operating cash flow of INR 27.46 billion supports its capital expenditures of INR 27.31 billion, suggesting that the company is reinvesting heavily in its operations. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. The company's capital expenditures are expected to remain high, driven by the need to expand its retail footprint and modernize its stores. The company's dilution risk is currently low, with no near-term pressure to issue additional shares. Recent filings and transcripts indicate that the company is focused on maintaining its market leadership in the Indian retail sector. The company has not disclosed any material risks or strategic shifts in its recent filings, suggesting a stable business environment.
Key takeaways
  • Avenue Supermarts Ltd has a strong liquidity position with a current ratio of 3.13.
  • The company's ROE and ROA are below industry medians, indicating underperformance in capital efficiency.
  • The company's revenue is concentrated in a single business segment, increasing exposure to regional risks.
  • Capital expenditures are expected to remain high, driven by expansion and modernization efforts.
  • Dilution risk is currently low, with no near-term pressure to issue additional shares.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$127.27B
Gross profit$18.39B
Operating income$7.41B
Net income$5.63B
R&D
SG&A
D&A
SBC
Operating cash flow$27.46B
CapEx-$27.31B
Free cash flow
Total assets$211.77B
Total liabilities$24.79B
Total equity$186.98B
Cash & equivalents$3.52B
Long-term debt$5.92B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$241.43B$13.34B$10.99B-$5.15B
FY-3$309.76B$20.08B$14.93B-$4.17B
FY-2$428.40B$30.05B$23.79B$8.10B
FY-1$507.89B$33.80B$25.36B$5.40B
FY0$593.58B$36.30B$27.08B$1.61B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$136.56B$121.84B$12.53B
FY-3$154.73B$136.78B$2.03B
FY-2$181.06B$160.79B$12.04B
FY-1$211.77B$186.98B$3.51B
FY0$243.20B$214.28B$16.3M
PeriodOCFCapExFCFSBC
FY-4$13.75B-$20.29B-$5.15B
FY-3$13.72B-$24.10B-$4.17B
FY-2$26.30B-$22.12B$8.10B
FY-1$27.46B-$27.31B$5.40B
FY0$24.63B-$34.23B$1.61B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$127.27B$7.41B$5.63B
FQ-6$140.69B$10.28B$7.74B
FQ-5$144.44B$8.86B$6.60B
FQ-4$159.73B$9.89B$7.24B
FQ-3$148.72B$7.14B$5.51B
FQ-2$163.60B$10.67B$7.73B
FQ-1$166.76B$9.60B$6.85B
FQ0$181.01B$11.95B$8.56B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$211.77B$186.98B$3.52B
FQ-6
FQ-5$230.40B$201.38B$3.05B
FQ-4
FQ-3$243.20B$214.28B$16.3M
FQ-2
FQ-1$269.14B$228.90B$2.10B
FQ0
PeriodOCFCapExFCFSBC
FQ-7$27.46B-$27.31B
FQ-6
FQ-5$10.35B-$15.96B
FQ-4
FQ-3$24.63B-$34.23B
FQ-2
FQ-1$13.98B-$17.53B
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$186.98B
Net cash-$2.40B
Current ratio3.1
Debt/Equity0.0
ROA2.7%
ROE3.0%
Cash conversion4.9%
CapEx/Revenue-21.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricAVEUActivity
Op margin5.8%3.1% medp25 1.2% · p75 6.8%above median
Net margin4.4%2.0% medp25 0.7% · p75 4.1%top quartile
Gross margin14.5%26.1% medp25 17.2% · p75 32.0%bottom quartile
CapEx / revenue-21.5%-2.5% medp25 -4.6% · p75 -1.4%bottom quartile
Debt / equity3.0%56.0% medp25 16.8% · p75 121.1%bottom quartile
Observations
IR observations
Mean price target4,329.28 INR
Median price target4,300.00 INR
High price target6,583.00 INR
Low price target3,100.00 INR
Mean recommendation2.90 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count7.00
Hold count12.00
Sell count6.00
Strong-sell count2.00
Mean EPS estimate46.77 INR
Last actual EPS41.50 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 07:13 UTC#6325c14c
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 10:32 UTCJob: 8f7c7771